CCF Presents Facebook Live with NET Expert Richard R.P. Warner, MD – April 19 at 1 pm, EST

April 16, 2019

You are invited to attend a Carcinoid Cancer Foundation Facebook Live event with Richard R.P. Warner, MD on Friday, April 19, 2019 at 1 pm, Eastern Standard Time. Dr. Warner will give an in-depth presentation on Carcinoid Syndrome and Serotonin. Considered one of the world’s leading experts on neuroendocrine cancer and carcinoid syndrome, Dr. Warner is Founder of the Carcinoid Cancer Foundation and Founder of the Center for Carcinoid and Neuroendocrine Tumors at Mount Sinai Health System in New York City.

Facebook Live with Richard R.P. Warner, MD, April 19, 2019, 1 pm EST

During his internal medicine internship and residency in the early 1950’s, a subspecialty in oncology was not yet recognized by a certifying board.  This led Dr. Warner to chose to pursue a gastroenterology fellowship in 1954.  His interest in carcinoid was sparked when he read an article in the American Heart Journal that mentioned a new syndrome characterized by diarrhea and facial flushing. This syndrome was associated with tumors in the small intestine that had spread to the liver and with prominent right-sided heart valve lesions.  It became known as carcinoid syndrome.


While serving in the Air Force Medical Corps during the Korean War in 1955, Dr. Warner encountered a patient with undiagnosed debilitating diarrhea and flushing and recalled the article he had read about carcinoid syndrome.  He wanted to investigate this further and it turns out this patient had a bronchial neuroendocrine tumor with carcinoid syndrome. Dr. Warner published an article about this which became the first description of carcinoid syndrome resulting from a bronchial carcinoid.


Dr. Warner’s interest in neuroendocrine tumors continued over the years and he became an expert in the field.  In October 2009 Dr. Warner was honored as the first recipient of the annual Lifetime Achievement Award of The North American Neuroendocrine Tumor Society (NANETS) for a lifetime of work and accomplishment with carcinoid and neuroendocrine tumors.  In 2012 he received the Distinguished Partner of Hope award of the Abramson Cancer Center of Penn Medicine Focus on Neuroendocrine Tumors. Dr. Warner retired from clinical practice in November 2016 to focus on research, lecturing, and patient advocacy.


If you have any non-case specific questions,  please send them our way via our Facebook page,, and Dr. Warner will try to answer them LIVE on April 19!

Categories: carcinoid syndrome
%d bloggers like this: